Clinical Trials Browser

Ependymoma, Glioblastoma, Glioma, Medulloblastoma, Meningioma, Neoplasms, Neurologic Manifestations

Brain Neoplasms, Breast Neoplasms

Carcinoma, Non-Small-Cell Lung, Meningeal Carcinomatosis

Brain Neoplasms, Small Cell Lung Carcinoma

Neuroblastoma

Esthesioneuroblastoma, Olfactory

Brain Neoplasms

Glioblastoma, Glioma, Neurofibromatosis 1

Diffuse Intrinsic Pontine Glioma, Brain Neoplasms, Glioma

Brain Neoplasms

Brain Neoplasms

Brain Neoplasms, Melanoma, Pancreatic Neoplasms

Ganglioneuroblastoma

Brain Neoplasms

Brain Neoplasms, Triple Negative Breast Neoplasms

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma

Neurofibromatosis 1, Sarcoma, Neurofibrosarcoma

Glioblastoma

Glioblastoma

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

Brain Neoplasms

Primary Glioblastoma

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

Neuroblastoma

Glioblastoma

Neuroblastoma

Brain Neoplasms, Lung Neoplasms

Glioblastoma

Neuroblastoma

Glioblastoma

Glioblastoma

Glioblastoma

Carcinoma, Non-Small-Cell Lung, Meningeal Carcinomatosis

Brain Neoplasms, Ependymoma, Glioma

Meningeal Carcinomatosis

Glioblastoma

Neurofibromatosis 1, Neurofibroma, Plexiform

Neurofibromatosis 1

Neurofibromatosis 1

Adenocarcinoma of Lung, Brain Neoplasms

Brain Neoplasms, Breast Neoplasms

Meningeal Carcinomatosis

Brain Neoplasms

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

Glioblastoma

Brain Neoplasms

Clinical Trials

FG001 Near-Infrared Fluorescence Imaging During Tumor Resection in Newly Diagnosed High-Grade Glioma

EViDENCE-BT

Brain Radiotherapy Combined With Dalpiciclib and Endocrine Therapy in HR-Positive/HER2-Negative Advanced Breast Cancer With Brain Metastases

Zorifertinib Plus Intra-Ommaya CSF Chemotherapy for Leptomeningeal Progression in NSCLC After Third-Generation EGFR-TKI

T-BRAIN

Patients Between the Ages of 12 Months to 21 Years With Newly-Diagnosed High-Risk Neuroblastoma Will Receive Children's Oncology Group (COG) Type Recommended Therapy With the Addition of Naxitamab and Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) to Induction Cycles 1-5

A Study of JZP3507 (ONC206) in Recurrent Grade 2 or 3 Meningioma

A Phase 2 Study Of Zanzalintinib For Patients With Recurrent Or Metastatic Olfactory Neuroblastoma

SMART Trial: Cognitive Sparing Brain Radiotherapy for Multiple Brain Metastases

NF118

Study of Tovorafenib in High-Grade Glioma and Diffuse Intrinsic Pontine Glioma (DIPG)

Memory Avoidance Whole Brain Radiotherapy vs Hippocampal Avoidance Whole Brain Radiotherapy (Athena 2 Trial)

A Phase II Clinical Study of Utidelone and Bevacizumab With or Without Etoposide in Patients With Brain Metastases From Malignant Solid Tumors

A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)

Comparing 123I-MIBG and 18F-MFBG Imaging in Patients With Newly Diagnosed, High Risk Neuroblastoma

MemoryRT

BERLIN

Direct Comparison of Ga-68-DOTATATE and Ga-68-DOTATOC

PRC

Trial of Selumetinib and Bromodomain Inhibitor With Durvalumab for Sarcomas

OPTICAL

Neoantigen-Pulsed Autologous Dendritic Cell Vaccine Combined With Temozolomide for Newly Diagnosed Glioblastoma

Furmonertinib 160mg vs 80mg + Chemotherapy in EGFR-Mutated NSCLC With Brain Metastases: Efficacy and Safety Study

A Multicenter Study to Assess the Feasibility of 5-Aminolevulinic Acid (5-ALA) in Pediatric Brain Tumor Patients

MATVAC-1

Sacituzumab Tirumotecan Plus Third-Generation TKI With/Without Radiotherapy for EGFR-Mutant NSCLC Brain Metastases

Phase II Study of Chidamide-Dinutuximab Beta-Irinotecan-Temozolomide for Refractory/Relapsed Neuroblastoma in Children

ReVoGlio

NANT 2021-02: Randomized MIBG With Vorinostat/Dinutuximab/Vorinostat + Dinutuximab

Sacituzumab Tirumotecan (Sac-TMT) Plus Bevacizumab in 3rd Generation EGFR-TKI Treated Advanced EGFR-mutant Nonsquamous NSCLC With Brain Metastasis

GLADIATOR

NEUROBLASTOTEP

Phase 2 Clinical Trial of KH617

IMAGLIO

A Phase II Clinical Study to Evaluate the Efficacy and Safety of Flazoparib Combined With Temozolomide After the Completion of Standard Concurrent Chemoradiotherapy (CCRT) in Newly Diagnosed Glioblastoma

GLIODIS

FLAME-1

P5A

Cerebrospinal Fluid Cytology-guided Intrathecal Chemo-holiday Therapy for EGFR-positive NSCLC Leptomeningeal Metastases

Vebreltinib Combined With Temozolomide for Glioblastoma (GBM) After Surgery

LS-NF1PNs

Clinical Study on the Treatment of Type I Neurofibromatosis With Smeitinib Hydrosulfate Capsule

The Clinical Study of the Treatment of Patients With Type I Neurofibromatosis With Smetinib Hydrosulfate Capsule

LungBrain001

Sacituzumab Govitecan Combined With Head Radiotherapy for Her2-negative Breast Cancer Brain Metastases

Double Dose of Third-generation EGFR-TKI Plus Intrathecal Pemetrexed Versus Double Dose of Third-generation EGFR-TKI in Patients With LM Progression Following the Treatment of Routine Dose of Third-generation EGFR-TKI

Nilatinib Maleate Tablets Combined With Capecitabine in the Treatment of HER2-positive Advanced Esophageal/Esophagogastric Junction/Gastric Adenocarcinoma With Brain Metastases

High-dose Furmonertinib Versus Osimertinib in Advanced EGFRm NSCLC Patients With Brain Metastases

The Effectiveness of HP and TMZ Synergism on Adult Recurrence GBM

SHR-A1921 Combined With Bevacizumab in Triple-negative Breast Cancer With Brain Metastases